Endogenous opioid peptides, endomorphin-1 and -2 and deltorphin I, stimulate angiogenesis in the CAM assay.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European Journal of Pharmacology

• Publication date

  2008-01-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPHAR.2007.10.015PMID 17976574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis

  2020cited by this paper
• Nonclassic endogenous novel [corrected] regulators of angiogenesis.

  2007cited by this paper
• High-dose Morphine Impairs Vascular Endothelial Function by Increased Production of Superoxide Anions

  2007cited by this paper
• Nonclassic Endogenous Novel Regulators of Angiogenesis

  2007cited by this paper
• Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation.

  2006cited by this paper
• Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells.

  2006cited by this paper
• Endogenous opiates and behavior: 2005.

  2006cited by this paper
• An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis

  2006cited by this paper
• Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis

  2005cited by this paper
• Anti-angiogenic therapy as a cancer treatment paradigm.

  2005cited by this paper
• Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.

  2005cited by this paper
• Opioids heal ischemic wounds in the rat

  2005cited by this paper
• Angiogenesis in psoriasis

  2004cited by this paper
• Differential expression of the human mu opiate receptor from different primary vascular endothelial cells.

  2004cited by this paper
• Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing

  2003cited by this paper
• Enhancement of Angiogenesis by Endogenous Substance P Release and Neurokinin-1 Receptors During Neurogenic Inflammation

  2003cited by this paper
• Endomorphins, endogenous opioid peptides, provide antioxidant defense in the brain against free radical-induced damage.

  2003cited by this paper
• Endomorphins inhibit contractile responses of rat thoracic aorta rings induced by phenylephrine and angiotensin II in vitro.

  2002cited by this paper
• Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.

  2002cited by this paper
• Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.

  2002cited by this paper
• Endomorphin-1 alters interleukin-8 secretion in Caco-2 cells via a receptor mediated process.

  2002cited by this paper
• Differential effects of vascular growth factors on arterial and venous angiogenesis.

  2002cited by this paper
• [Effects of endomorphins and their analogs on cardiovascular system].

  2001cited by this paper
• Ischemic preconditioning - an opiate constitutive nitric oxide molecular hypothesis.

  2001cited by this paper
• Opioid growth factor modulates angiogenesis.

  2000cited by this paper
• Acute Effects of Morphine on Blood Lymphocyte Proliferation and Plasma IL‐6 Levels

  2000cited by this paper
• Human vascular and cardiac endothelia express mu opiate receptor transcripts.

  2000cited by this paper
• Treatment of painful skin ulcers with topical opioids.

  1999cited by this paper
• Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.

  1999cited by this paper
• Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the rat.

  1999cited by this paper
• Potential uses of topical opioids in palliative care--report of 6 cases.

  1999cited by this paper
• Clinical research on antiangiogenic therapy.

  1998cited by this paper
• δ2 opioid receptor subtype on human vascular endothelium uncouples morphine stimulated nitric oxide release

  1998cited by this paper
• D-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats.

  1998cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• d-[Ala2]endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats.

  1998cited by this paper
• Delta2 opioid receptor subtype on human vascular endothelium uncouples morphine stimulated nitric oxide release.

  1998cited by this paper
• Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.

  1997cited by this paper
• New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.

  1997cited by this paper
• Immunocytochemical localization of μ-opioid receptors in follicular cells and preimplantation mouse embryos

  1997cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Immunocytochemical localization of mu-opioid receptors in follicular cells and preimplantation mouse embryos.

  1997cited by this paper
• Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene.

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Central opiate modulation of peripheral IL‐6 in rats

  1996cited by this paper
• Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb.

  1996cited by this paper
• Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia.

  1996cited by this paper
• Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

  1996cited by this paper
• Clinical Applications of Research on Angiogenesis

  1995cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Immune activation: the role of pro‐inflammatory cytokines in inflammation, illness responses and pathological pain states

  1995cited by this paper
• Dual Pathways to Tubular Morphogenesis of Vascular Endothelial Cells by Human Glioma Cells: Vascular Endothelial Growth Factor/Basic Fibroblast Growth Factor and Interleukin‐8

  1995cited by this paper
• Angiogenesis inhibition: a review.

  1994cited by this paper
• Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane.

  1994cited by this paper
• Angiogenesis and colonization in the tumor metastatic process: basic and applied advances

  1994cited by this paper
• Stimulation of angiogenesis by substance P and interleukin‐1 in the rat and its inhibition by NK1 or interleukin‐1 receptor antagonists

  1993cited by this paper
• Endothelial cell migratory signal produced by human endometrium during the menstrual cycle.

  1992cited by this paper
• The role of angiogenesis in tumor growth.

  1992cited by this paper
• Regulators of angiogenesis.

  1991cited by this paper
• Angiogenesis: modulation with opioids.

  1991cited by this paper
• A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors

  1991cited by this paper
• What is the evidence that tumors are angiogenesis dependent?

  1990cited by this paper
• [Effects of opioids on the development of preimplantation mouse embryos].

  1989cited by this paper
• Differential maturation of mu and delta opioid receptors in the chick embryonic brain.

  1987cited by this paper
• Mechanisms of angiogenesis.

  1987cited by this paper
• Differential maturation of μ and δ opioid receptors in the chick embryonic brain

  1987cited by this paper
• A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.

  1985cited by this paper
• Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.

  1985cited by this paper
• Role of prostaglandin E1 and copper in angiogenesis.

  1982cited by this paper
• [3H]Etorphine binding activity in early chick embryos: brain and body tissue.

  1982cited by this paper
• Morphometry of diabetic conjunctival blood vessels.

  1981cited by this paper
• Continuous exposure of the chick embryo to l-alpha-noracetylmethadol does not alter brain protein or nucleic acid content.

  1981cited by this paper
• Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study.

  1974cited by this paper
• Proceedings: Tumor angiogenesis factor.

  1974cited by this paper
• THE CHORIO-ALLANTOIS OF THE CHICK. LIGHT AND ELECTRON MICROSCOPIC OBSERVATIONS AT VARIOUS TIMES OF INCUBATION.

  1963cited by this paper

• Effects of Central Administration of Opioid Peptides, Vasotocin, Mesotocin, and Corticotrophin-Releasing Factor on Water Intake in Chicks

  2025cites this paper
• The Role of Opioid Receptors in Cancer

  2023cites this paper
• The other side of the coin: Positive view on the role of opioids in cancer.

  2022cites this paper
• Thebaine Derivatives as a New Regulator of Tumor Angiogenesis

  2021cites this paper
• Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.

  2020cites this paper
• Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer

  2020cites this paper
• Comparative Experimental Studies of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers against Two Different Models of Angiogenesis

  2019cites this paper
• Opioids: Modulators of angiogenesis in wound healing and cancer

  2017cites this paper
• Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma.

  2015cites this paper
• Inhibitory effect of deltorphin-II on development of malaria in Plasmodium berghei-infected mice

  2015cites this paper
• Opioids and neovascularization; pro or anti?

  2015cites this paper
• Opioid Regulation of Vascular Integrity

  2013cites this paper
• BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice.

  2013cites this paper
• Thiabendazole, a well-known antifungal drug, exhibits anti-metastatic melanoma B16F10 activity via inhibiting VEGF expression and inducing apoptosis.

  2013cites this paper
• Engineering endomorphin drugs: state of the art

  2012cites this paper
• Hemokinins modulate endothelium function and promote angiogenesis through neurokinin-1 receptor.

  2012cites this paper
• The &mgr;-Opioid Receptor in Cancer Progression: Is There a Direct Effect?

  2012cites this paper
• Morphine and tumor growth and metastasis

  2011cites this paper
• The stimulative effects of endogenous opioids on endothelial cell proliferation, migration and angiogenesis in vitro.

  2010cites this paper
• The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis

  2010cites this paper
• Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression.

  2009cites this paper
• Endogenous opiates and behavior: 2008.

  2009cites this paper
• Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.

  2008cites this paper